Dabigatran Etexilate Mesylate
Dabigatran Etexilate Mesylate is an orally bioavailable prodrug that is rapidly converted to dabigatran, a potent, selective, and reversible direct thrombin inhibitor (Ki = 4.5 nM) . It is widely used in research to study anticoagulation mechanisms and efficacy in both in vitro biochemical assays and in vivo thrombosis models.
Product Specifications
CAS Number
872728-81-9
Product Name Alternative
BIBR 1048MS, antithrombotic, anticoagulant, atrial, active, agent, Dabigatran etexilate, Dabigatran Etexilate Mesylate, Dabigatran etexilate methanesulfonate, Dabigatran, inhibit, orally, fibrillation, effects, Inhibitor, venousthromboembolism, prodrug, Thrombin
Field of Research
Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.91% (May vary between batches)
Solubility
DMSO:245 mg/mL (338.47 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.76 mM)
Smiles
CS (O) (=O) =O.CCCCCCOC (=O) NC (=N) c1ccc (NCc2nc3cc (ccc3n2C) C (=O) N (CCC (=O) OCC) c2ccccn2) cc1
Molecular Formula
C34H41N7O5.CH4O3S
Molecular Weight
723.84
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
